Lung cancer is one of the world's biggest killers. In the UK, it accounts for six per cent of all deaths, largely because treatment is often ineffective by the time symptoms are diagnosed.
Researchers at the University of Huddersfield are developing the device that will be able to detect very early signs of the disease, making a cure much more likely.
It will be pharmacists who administer a test that has the potential to save hundreds of thousands of lives, researchers said.
The project has received financial backing from Dr Philip Brown of the SG Court Group, a pharmacy chain based in the South East of England, where initial trials will be carried out.
"We are looking to be able to distinguish between patients with early lung cancer and patients who have maybe got bronchitis, emphysema or non-malignant smoking related disease...Or who have maybe just got a cough," Airley said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
